Treatment of Akata EBV-positive cells with doxorubicin causes more EBV reactivation than treatment with etoposide.
about
Zidovudine-based lytic-inducing chemotherapy for Epstein-Barr virus-related lymphomas.Sulfated small molecules targeting eBV in Burkitt lymphoma: from in silico screening to the evidence of in vitro effect on viral episomal DNA.Icaritin induces lytic cytotoxicity in extranodal NK/T-cell lymphoma.EBV in pediatric neoplasia--intensity of infection as independent prognostic factorEpstein-Barr virus-targeted therapy in nasopharyngeal carcinoma.Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.Therapies based on targeting Epstein-Barr virus lytic replication for EBV-associated malignancies.
P2860
Q34053519-7ED1D8A3-E419-4949-AF61-AC625C962760Q34563797-9A9F2DF7-9E53-4172-AE0D-6E06BA05D05FQ35107719-2D1530CB-59D9-4BA8-906F-925383FCAFA3Q36299804-E74A92A4-D392-47D1-BF40-76246668BCF7Q42145376-E6507625-CE8D-446A-BE61-FA4A915111B0Q54217772-CCD87507-F17B-496E-A6E9-EC60A8071216Q55518172-C0A31A1C-1220-4FA3-8B54-12F5DB10608E
P2860
Treatment of Akata EBV-positive cells with doxorubicin causes more EBV reactivation than treatment with etoposide.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Treatment of Akata EBV-positiv ...... than treatment with etoposide.
@en
Treatment of Akata EBV-positiv ...... than treatment with etoposide.
@nl
type
label
Treatment of Akata EBV-positiv ...... than treatment with etoposide.
@en
Treatment of Akata EBV-positiv ...... than treatment with etoposide.
@nl
prefLabel
Treatment of Akata EBV-positiv ...... than treatment with etoposide.
@en
Treatment of Akata EBV-positiv ...... than treatment with etoposide.
@nl
P2093
P2860
P356
P1433
P1476
Treatment of Akata EBV-positiv ...... than treatment with etoposide.
@en
P2093
M Helena Vasconcelos
Maria S J Nascimento
Susana Brás
P2860
P304
P356
10.1159/000323627
P577
2011-04-29T00:00:00Z